Avanos Medical Inc
(AVNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 92,200 | 75,800 | 87,700 | 107,100 | 81,800 |
| Receivables | 123,000 | 131,300 | 142,800 | 145,200 | 152,300 |
| Inventories | 163,900 | 165,600 | 163,200 | 156,600 | 148,300 |
| Other current assets | 72,700 | 66,500 | 64,500 | 102,100 | 108,700 |
| TOTAL | $474,100 | $467,800 | $487,000 | $524,600 | $506,900 |
| Non-Current Assets | |||||
| PPE Net | 110,700 | 116,200 | 117,200 | 116,800 | 122,600 |
| Intangibles | 1,020,600 | 1,027,700 | 1,035,600 | 1,033,700 | 985,200 |
| Other Non-Current Assets | 52,400 | 49,600 | 52,600 | 49,800 | 52,000 |
| TOTAL | $1,183,700 | $1,193,500 | $1,205,400 | $1,200,300 | $1,159,800 |
| Total Assets | $1,657,800 | $1,661,300 | $1,692,400 | $1,724,900 | $1,666,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,200 | 9,400 | 8,600 | 6,200 | 6,200 |
| Accounts payable and accrued liabilities | 51,400 | 57,000 | 56,300 | 52,100 | 65,400 |
| Accrued Expenses | 79,500 | 75,100 | 93,200 | 97,200 | 72,700 |
| Other current liabilities | 52,700 | 52,200 | 63,700 | 2,500 | 2,700 |
| TOTAL | $208,200 | $205,200 | $234,600 | $170,700 | $160,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 164,900 | 167,200 | 159,400 | 258,300 | 203,300 |
| Other Non-Current Liabilities | 39,300 | 37,400 | 38,300 | 45,100 | 46,300 |
| TOTAL | $227,600 | $228,200 | $221,500 | $332,100 | $271,400 |
| Total Liabilities | $435,800 | $433,400 | $456,100 | $502,800 | $431,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,949 | 45,904 | 46,203 | 46,426 | 46,873 |
| Common Shares | 500 | 500 | 500 | 500 | 500 |
| Retained earnings | -314,000 | -315,800 | -314,900 | -325,400 | -321,700 |
| Other shareholders' equity | -37,000 | -29,500 | -26,900 | -32,700 | -27,900 |
| TOTAL | $1,222,000 | $1,227,900 | $1,236,300 | $1,222,100 | $1,234,800 |
| Total Liabilities And Equity | $1,657,800 | $1,661,300 | $1,692,400 | $1,724,900 | $1,666,700 |